Clinical trial
Unraveling the Role of JAK1 and JAK2 Pathway in Periodontitis: Drivers of Immunopathology and Possible Therapeutic Targets
NCT07536204 is registered in ClinicalTrials.gov with University of Chile as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Unraveling the Role of JAK1 and JAK2 Pathway in Periodontitis: Drivers of Immunopathology and Possible Therapeutic Targets
- Lead sponsor
- University of Chile
- Phase
- Observational
- Overall status
- Recruiting
- Start date
- June 1, 2023
- Completion date
- March 31, 2027
- Enrollment
- 30 (estimated)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.
gingival diseases, periodontal attachment loss, periodontal diseases, periodontal inflammation, periodontitis